Navigation Links
Delcath Systems, Inc. Completes Phase III Study Enrollment
Date:10/21/2009

NEW YORK, Oct. 21 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH), a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced today that its pivotal Phase III Metastatic Melanoma Trial has met its goal of 92 patients and is fully enrolled. This clinical study is evaluating the Delcath PHP System(TM) for the regional delivery of melphalan to the liver to treat patients with metastatic cutaneous and ocular melanoma who have unresectable tumors in the liver.

With the achievement of complete enrollment, the company remains on-track for a FDA submission of its Delcath PHP System(TM) with melphalan in 2010. Trial enrollment will continue for the near-term to include additional patients that have begun the evaluation process and may be eligible to participate.

"We always expected to see the greatest enrollment activity in the second half of the study period as positive word about the Delcath PHP System spread and attracted new patients to the study," said Eamonn Hobbs, President and CEO of Delcath Systems. "We are delighted to have completed enrollment on-plan, and to continue the extremely positive momentum created over the last six months. We have achieved several key, strategic milestones, including the successful review of our Phase III safety data, orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma, and the additions of David McDonald as Chief Financial Officer and Dr. Krishna Kandarpa as Chief Medical Officer and EVP of Research and Development. We also executed on our plans to build our own manufacturing facility, which we will continue to develop as we focus for the remainder of the year on preparation for our FDA submission, commercialization and international licensing."

About the Phase
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
2. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
3. Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Lukes Cancer Center
4. Delcath Adds Dr. Pamela R. Contag to Its Board of Directors
5. Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM)
6. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent Accrual
7. Data Safety Monitoring Board Unanimously Recommends Continuation of Delcaths Phase III Clinical Trial
8. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
9. SELECT TRIAL Used Selenomethionine Instead of High-Selenium Yeast, SelenoExcell(R) - Previous Research has Shown SelenoExcell(R) Supplementation to Reduce Lung, Colon and Prostate Cancers by as Much as 63%, Says Cypress Systems, Inc.
10. Guided Delivery Systems, Inc. Successfully Treats First Patient with Mitral Regurgitation
11. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... According to a new market research report " ... Stimulation, Transcranial Magnetic Stimulation), Application (Depression, Parkinson,s, Tinnitus, Alzheimer,s, Epilepsy, ... MarketsandMarkets, the global Neuromodulation Market is estimated at $3.65 Billion ... 2020, at a CAGR of 11.2% during the forecast period. ... market data T ables and 32 ...
(Date:7/2/2015)... , July 2, 2015  The Green Exchange, Inc., ... world,s first HIPAA compliant mobile app that connects cannabis ... fresh medical marijuana, announced today that their service provides ... Eaze, Meadow and more than half a dozen other ... year, Loud Cannabis is unique in that it ...
(Date:7/2/2015)... , and DURHAM, N.C. , ... Inc. today announced its acquisition of assets related to ... PFE ) that had previously been obtained as ... Sciences also acquired all of Pfizer,s rights to the ... Icagen brand and will provide comprehensive services for ion ...
Breaking Medicine Technology:Neuromodulation Market Worth $6.20 Billion by 2020 2Neuromodulation Market Worth $6.20 Billion by 2020 3Neuromodulation Market Worth $6.20 Billion by 2020 4New Cannabis Delivery App Gets Product to Patient in Under 7 Minutes 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4
... Amira Pharmaceuticals, Inc. today announced that the U.K. Intellectual ... (FLAP) Inhibitors," which includes coverage of Amira,s AM103 and AM803 FLAP ... , , ... and GlaxoSmithKline (GSK) entered into a worldwide exclusive agreement allowing GSK ...
... Md. , July 13 Hanger Orthopedic Group, Inc. (NYSE: HGR ... ended June 30, 2010 , on Tuesday, July 27, 2010 . , ... The Company plans to issue a press release announcing the results for ... after the close of the market. The conference call is scheduled to begin at ...
Cached Medicine Technology:Amira Announces AM103 and AM803 Patent Grant in the United Kingdom 2Hanger Orthopedic Group, Inc. Announces Second Quarter 2010 Earnings Release Conference Call 2
(Date:7/4/2015)... ... July 05, 2015 , ... Dating a real millionaire online ... best online millionaire dating service and strives to remove the worries from meeting partners. ... millionaire dating app of 2015 and readers have responded with excitement. ...
(Date:7/4/2015)... ... July 04, 2015 , ... Tyler Boden, Project Developer ... sales expertise from the North American Board of Certified Energy Practitioners (NABCEP®), and ... highly respected and well established national certification organization for renewable energy professionals. Designation ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... its 2015 Annual Conference , the premiere continuing education and networking ... Orlando at SeaWorld in Orlando, Florida. Speakers include the leading rheumatology experts ...
(Date:7/3/2015)... , ... July 03, 2015 , ... ... to healthcare providers, has been retained to lead a national chief nursing ... the top-ranked executive search firms in the healthcare industry, B. E. Smith has ...
(Date:7/3/2015)... ... July 03, 2015 , ... Jennifer Renee Hanes, DO is the new ... the largest network of independent freestanding emergency rooms in the United States. , “We ... Sienna Plantation facility,” said Executive Medical Director of First Choice Emergency Room, Dr. James ...
Breaking Medicine News(10 mins):Health News:MillionaireMatchapp.com Publishes the Best Millionaire Dating App and Official Dating Site Reviews 2015 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3
... (August 15, 2011) Autism Speaks, the world,s largest autism ... the largest known study of younger siblings of children who ... study, based on data from the Autism Speaks High Risk ... the UC Davis MIND Institute, was published online today in ...
... are at an increased risk of dying due to ... BioMed Central,s open access journal Arthritis Research & ... for people with RA is due to disease-related inflammation ... general population. Treatment of arthritis with disease modifying antirheumatic ...
... Aug. 13 (HealthDay News) -- Although many children anxiously anticipate ... about the transition than others. Children who are excessively ... larger problem, an expert says. "Even though most children ... quite happy and adjust to the new school within two ...
... Standing water is a breeding ground for mosquitoes that can ... many urban families don,t take simple steps such as dumping ... Last summer, researchers polled 242 urban residents to find out ... risks posed by standing water, a mosquito breeding ground. Researchers ...
... disease who go to a neurologist for their care are more ... nursing home and less likely to break a hip than people ... published in the August 10, 2011, online issue of Neurology, ... The study also found that women and minorities were ...
... News) -- More doctors are performing weight-loss surgery today, ... study finds. Researchers analyzing trends in bariatric surgery ... as adjustable gastric banding, has led to a greater ... , "We,ve identified a national trend ...
Cached Medicine News:Health News:Risk of autism among younger siblings of a child with autism much greater than previously reported 2Health News:Planning Ahead Can Reduce Back-to-School Stress 2Health News:Get Rid of Standing Water to Protect From Mosquitoes 2Health News:Study suggests seeing a neurologist helps people with Parkinson's live longer 2Health News:Weight-Loss Surgery Gains More Practitioners 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: